Skip to main content
Have a personal or library account? Click to login
Integrated Genomic Analysis of Breast Cancers Cover

Integrated Genomic Analysis of Breast Cancers

Balkan Journal of Medical Genetics
Volume 15 (2012): Issue Supplement (December 2012)
By: ,  ,  ,  ,  ,  ,  ,  ,  ,   and    
Open Access
|Dec 2012
References

References

  1. 1. Solinas-Toldo S, Lampel S, Stilgenbauer S,Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances.Genes Chromosomes Cancer. 1997; 20(4): 399-407.
    Open DOISearch in Google Scholar
  2. 2. Pinkel D, Segraves R, Sudar D,High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet. 1998; 20(2): 207-211.
    Open DOISearch in Google Scholar
  3. 3. van Beers EH, Nederlof PM. Array-CGH and breast cancer. Breast Cancer Res. 2006; 8(3): 210-219.
    Open DOISearch in Google Scholar
  4. 4. Curtis C, Lynch AG, Dunning MJ,The pitfalls of platform comparison: DNA copy number array technologies assessed. BMC Genomics. 2009; 10: 588-610.
    Open DOISearch in Google Scholar
  5. 5. Bertucci F, Houlgatte R, Nguyen C, Viens P, Jordan BR, Birnbaum D. Gene expression profiling of cancer by use of DNA arrays: how far from the clinic? Lancet Oncol. 2001; 2(11): 674-682.
    Open DOISearch in Google Scholar
  6. 6. Perou CM, Sørlie T, Eisen MB,Molecular portraits of human breast tumours. Nature. 2000; 406 (6797): 747-752.
    Open DOISearch in Google Scholar
  7. 7. Sørlie T, Perou CM, Tibshirani R,Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001; 98(19): 10869-10874.
    Open DOISearch in Google Scholar
  8. 8. Sotiriou C, Pusztai L. Gene-expression signatures in breast cancer. N Engl J Med. 2009; 360(8): 790-800.
    Open DOISearch in Google Scholar
  9. 9. Chang JC, Wooten EC, Tsimelzon A,Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet. 2003; 362(9381):362-369.
    Open DOISearch in Google Scholar
  10. 10. Ayers M, Symmans WF, Stec J,Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer. J Clin Oncol. 2004; 22(12): 2284-2293.
    Open DOISearch in Google Scholar
  11. 11. Bonnefoi H, Potti A, Delorenzi M,Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial. Lancet Oncol. 2007; 8(12): 1071-1078.
    Open DOISearch in Google Scholar
  12. 12. Farmer P, Bonnefoi H, Anderle P,A stromarelated gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nat Med. 2009; 5(1): 68-74.
    Open DOISearch in Google Scholar
  13. 13. Dunn L, Demichele A. Genomic predictors of outcome and treatment response in breast cancer. Diagn Mol Ther. 2009; 13(2): 73-90.
    Open DOISearch in Google Scholar
  14. 14. Gelsi-Boyer V, Trouplin V, Adélaïde J,Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes. BMC Cancer. 2008; 8: 299-313.
    Open DOISearch in Google Scholar
  15. 15. Bergamaschi A, Kim YH, Wang P,Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosomes Cancer. 2006; 45(11): 1033-1040.
    Open DOISearch in Google Scholar
  16. 16. Chin K, de Vries S, Fridlyand J,Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell. 2006; 10(6): 529-541.
    Open DOISearch in Google Scholar
  17. 17. Stransky N, Vallot C, Reyal F,Regional copy number-independent deregulation of transcription in cancer. Nat Genet. 2006; 38(12): 1386-1396.
    Open DOISearch in Google Scholar
  18. 18. Neve RM, Chin K, Fridlyand J,A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 2006; 10(6): 515-527.
    Open DOISearch in Google Scholar
  19. 19. Adélaïde J, Finetti P, Bekhouche I,Integrated profiling of basal and luminal breast cancers. Cancer Res. 2007; 67(24): 11565-11575.
    Open DOISearch in Google Scholar
  20. 20. Chin SF, Teschendorff AE, Marioni JC,Highresolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Genome Biol. 2007; 8(10): R215-R231.
    Open DOISearch in Google Scholar
  21. 21. Bernard-Pierrot I, Gruel N, Stransky N,Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer. Cancer Res. 2008; 68(17): 7165-7175.
    Open DOISearch in Google Scholar
  22. 22. Vincent-Salomon A, Lucchesi C, Gruel N,Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast. Clin Cancer Res. 2008; 14(7): 1956-1965.
    Open DOISearch in Google Scholar
  23. 23. André F, Job B, Dessen P,Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array. Clin Cancer Res. 2009; 15(2): 441-451.
    Open DOISearch in Google Scholar
  24. 24. Horlings HM, Lai C, Nuyten DS,Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients. Clin Cancer Res. 2010; 16(2): 651-663.
    Open DOISearch in Google Scholar
  25. 25. Popovici C, Basset C, Bertucci F,Reciprocal translocations in breast tumor cell lines: cloning of a t(3;20) that targets the FHIT gene. Genes Chromosomes Cancer. 2002; 35(3): 204-218.
    Open DOISearch in Google Scholar
  26. 26. Adélaïde J, Huang HE, Murati A,A recurrent chromosome translocation breakpoint in breast and pancreatic cancer targets the heregulin/NRG1 gene at 8p12. Genes Chromosomes Cancer. 2003; 37(4): 333-345.
    Open DOISearch in Google Scholar
  27. 27. Huang HE, Chin S-F, Ginestier C,A recurrent chromosome breakpoint in breast cancer at the NRG1/ neuregulin 1/heregulin gene. Cancer Res. 2004; 64(19): 6840-6844.
    Open DOISearch in Google Scholar
  28. 28. Letessier A, Ginestier C, Charafe-Jauffret E,ETV6 gene rearrangements in invasive breast carcinoma. Genes Chromosomes Cancer. 2005; 44(1): 103-108.
    Open DOISearch in Google Scholar
  29. 29. Letessier A, Garrido-Urbani S, Ginestier C,Correlated break at PARK2/FRA6E and loss of AF- 6/ Afadin protein expression are associated with poor outcome in breast cancer. Oncogene. 2007; 26(2): 298-307.
    Open DOISearch in Google Scholar
  30. 30. Ginestier C, Bardou V-J, Popovici C,Absence of FHIT protein expression correlates with adverse evolution in good prognosis localized breast cancer. Int J Cancer. 2003; 107(5): 854-862.
    Open DOISearch in Google Scholar
  31. 31. Letessier A, Sircoulomb F, Ginestier C,Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers. BMC Cancer. 2006; 6(1): 245-257.
    Open DOISearch in Google Scholar
  32. 32. Bekhouche I, Finetti P, Adélaïde J,Genome profiling of inflammatory breast cancer. PLoS One. 2011; 6(2): e16950-16962.
    Open DOISearch in Google Scholar
  33. 33. Sircoulomb F, Bekhouche I, Finetti P,Genome profiling of ERBB2-amplified breast cancers. BMC Cancer. 2010; 10: 539-556.
    Open DOISearch in Google Scholar
  34. 34. Addou-Klouche L, Adélaïde J, Finetti P,Loss, mutation and deregulation of L3MBTL4 in breast cancers. Mol Cancer. 2010; 9(1): 213-225.
    Open DOISearch in Google Scholar
  35. 35. Sircoulomb F, Nicolas N, Ferrari A,gene amplification at 8p12 specifies luminal B breast cancer. EMBO Mol Med. 2011; 3(3): 153-166.
    Open DOISearch in Google Scholar
  36. 36. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002; 3(6): 415-428.
    Open DOISearch in Google Scholar
  37. 37. Lund AH, van Lohuizen M. Epigenetics and cancer. Genes Dev. 2004; 18(19): 2315-2335.
    Open DOISearch in Google Scholar
  38. 38. Rice KL, Hormaeche I, Licht JD. Epigenetic regulation of normal and malignant hematopoiesis. Oncogene. 2007; 26(47): 6697-6714.
    Open DOISearch in Google Scholar
  39. 39. Goll MG, Bestor TH. Histone modification and replacement in chromatin activation. Genes Dev. 2002; 16(14): 1739-1742.
    Open DOISearch in Google Scholar
  40. 40. Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci. 2006; 31(2): 89-97.
    Open DOISearch in Google Scholar
  41. 41. Esteller M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet. 2007; 16(Spec 1): R50-R59.
    Open DOISearch in Google Scholar
  42. 42. Wildschwendter M, Jones PA. DNA methylation and breast carcinogenesis. Oncogene. 2002; 21(35): 5462-5482.
    Open DOISearch in Google Scholar
  43. 43. Mulero-Navarro S, Esteller M. Epigenetic biomarkers for human cancer: The time is now. Crit Rev Oncol Hematol. 2008; 68(1): 1-11.
    Open DOISearch in Google Scholar
  44. 44. Ordway JM, Budiman MA, Korshunova Y,Identification of novel high-frequency DNA methylation changes in breast cancer. PLoS One. 2007; 2(12): e1314-1325.
    Open DOISearch in Google Scholar
  45. 45. Bediaga NG, Acha-Sagredo A, Guerra I,DNA methylation epigenotypes in breast cancer molecular subtypes. Breast Cancer Res. 2010; 12(5): R77-R78.
    Open DOISearch in Google Scholar
  46. 46. Holm K, Hegardt C, Staaf J,Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns. Breast Cancer Res. 2010; 12 (3): R36-R51.
    Open DOISearch in Google Scholar
  47. 47. van der Auwera I, Yu W, Suo L,Array-based DNA methylation profiling for breast cancer subtype discrimination. PLoS One. 2010; 5(9): e12616-12625.
    Open DOISearch in Google Scholar
  48. 48. Fackler MJ, Umbricht CB, Williams D,Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. Cancer Res. 2011; 71(19): 6195-6207.
    Open DOISearch in Google Scholar
  49. 49. Hill VK, Ricketts C, Bieche I,Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity. Cancer Res. 2011; 71(8): 2988-2999.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10034-012-0023-x | Journal eISSN: 2199-5761 (formerly 1311-0160) | Journal ISSN: 1311-0160
Journal RSS Feed
Language: English
Page range: 71 - 74
Published on: Dec 22, 2012
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Keywords:
Breast cancers,
Genome,
Transcriptome,
Epigenome,
Oncogenes,
Tumor suppressor genes
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other

© 2012 Max Chaffanet, L Addou-Klouche, J Adélaïde, S Cornen, I Bekhouche, P Finetti, A Guille, F Sircoulomb, S Raynaud, F Bertucci, D Birnbaum, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons License.

Volume 15 (2012): Issue Supplement (December 2012)
Previous article
Next article